Skip to main content
HeartCited

Berberine untuk Metabolic Syndrome (Cardiovascular Aspects)

B Bukti Setidaknya satu uji coba acak mendukung hal ini, dengan hasil yang sebagian besar konsisten.

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome\u002Dcardiovascular'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Kesimpulan

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None vs: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance Efek: None None

Populasi: MCD diet-induced MASH C57BL/6J male mice

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None vs: None Outcome: None Efek: None None

Populasi: Alzheimer's disease patients

Key Statistics

20

Studi

2500

Peserta

Positive

B

Peringkat

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:
500-1,500 mg/day divided TID
lipidsupport:
500 mg TID with meals

Batas atas: Not formally established; GI side effects limit doses >1,500 mg/day

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

Waktu terbaik diminum: With meals, divided TID for sustained plasma levels; short half-life

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Diarrhea (most common, usually resolves in 2 weeks)
  • Constipation
  • Flatulence
  • Abdominal pain
  • May lower blood sugar (monitor in diabetics)

Interaksi yang Diketahui

  • Metformin (additive blood sugar lowering; may increase metformin levels)
  • CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
  • Cyclosporine (may increase blood levels)
  • Macrolide antibiotics (may prolong QT interval)
  • Statins (complementary mechanism; monitor for additive effects)

Asupan atas yang dapat ditoleransi: Not formally established; GI side effects limit doses >1,500 mg/day

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome (Cardiovascular Aspects)?
Based on 20 studies with 2,500 participants, there is moderate evidence from clinical studies that Berberine may support Metabolic Syndrome (Cardiovascular Aspects) management. Our evidence grade is B (Good Evidence).
How much Berberine should I take for Metabolic Syndrome (Cardiovascular Aspects)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day divided TID. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea (most common, usually resolves in 2 weeks), Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome (Cardiovascular Aspects)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.